• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of FDA advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of December 31, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20111019
Nov 20111024
Dec 20111022
Jan 20121023
Feb 20121020
Mar 20121019
Apr 20121017
May 20121017
Jun 20121018
Jul 20121022
Aug 20121022
Sep 20121022

Number of FDA advisory committee member positions vacant at the end of the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2011N/A118
Nov 2011N/A149
Dec 2011N/A137
Jan 2012N/A145
Feb 2012N/A126
Mar 2012N/A120
Apr 2012N/A110
May 2012N/A106
Jun 2012N/A117
Jul 2012N/A141
Aug 2012N/A137
Sep 2012N/A137

Total number of FDA advisory committee member positions at the end of the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2011N/A621
Nov 2011N/A621
Dec 2011N/A621
Jan 2012N/A621
Feb 2012N/A621
Mar 2012N/A621
Apr 2012N/A634
May 2012N/A634
Jun 2012N/A634
Jul 2012N/A634
Aug 2012N/A634
Sep 2012N/A634

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.